ORWH and the Food and Drug Administration (FDA) Office of Women’s Health (OWH) have released the first three modules of the e-learning course Bench to Bedside: Integrating Sex and Gender to Improve Human Health.
Cardiologist Nakela Cook, M.D., M.P.H., currently a Senior Scientific Officer and Chief of Staff in the Immediate Office of the Director (IOD) of the National Heart, Lung, and Blood Institute (NHLBI), will take on a new role as the Executive Director of the Patient-Centered Outcomes Research Institute (PCORI) on April 15.
The National Institute of General Medical Sciences (NIGMS), ORWH, and other NIH institutes and centers recently released a notice of special interest (NOSI) announcing “Administrative Supplements for Research on Women’s Health in the IDeA States” (NOT-GM-20-017).
The Black Mamas Matter Alliance is sponsoring the third annual Black Maternal Health Week as part of the observation of National Minority Health Month in April.
A recent request for information (RFI) from NIH invites comments and suggestions on a proposal for a trans-NIH research initiative to reduce maternal mortality.
The NIH Advisory Committee on Research on Women’s Health (ACRWH) will meet on the NIH main campus (John Edward Porter Neuroscience Research Center, Building 35A, Rooms 620/630) on April 21, 2020, from 9:00 a.m. to 5:00 p.m. (Eastern).
Jacqueline Howard of CNN.com recently interviewed ORWH Director Janine A. Clayton, M.D., for an article on maternal mortality.
NIH recently published two notices of special interest (NOSIs) announcing administrative supplements to support and enhance retention of early-career biomedical investigators during critical life events.
The Journal of Women’s Health recently published “Sex as a Biological Variable: A 5-Year Progress Report and Call to Action,” an article commenting on the development and implementation of NIH’s SABV policy, which went into effect in January 2016.
NIH recently published two notices of special interest (NOSIs) announcing administrative supplements being offered by ORWH.
The annual meeting of the Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) program was held on December 11, 2019, on the NIH main campus. Keynote speaker Judith Regensteiner, Ph.D., delivered the Ruth L. Kirschstein Memorial Lecture, titled “Strategic Career Development: Charting the Course.”
A new section of the ORWH website features free online courses designed to give users a thorough and up-to-date understanding of sex and gender influences on health and disease and NIH requirements on factoring sex as a biological variable into research design.
ORWH is offering two Science Policy Scholar Travel Awards to support the development of junior investigators focused on women’s health or sex and gender differences who are also interested in research policy.
ORWH recently launched a revised NIH Inclusion Outreach Toolkit to help researchers recruit and retain women participants in their clinical studies.
A recent perspective piece in Nature explores how incorporating analysis of sex and gender into scientific and engineering research can engender discovery, increase experimental reproducibility and efficiency, suggest new methodologies, and promote social equity...
The NIH Pathway to Independence Awards (K99/R00) help outstanding postdoctoral researchers complete mentored training and transition in a timely manner to independent, tenure-track, or equivalent faculty positions...
The Washington Post and Clinical Practice Today Interview ORWH Director About PTSD and Gender Bias in Patient Care
ORWH hosted the fall 2019 meeting of the NIH Advisory Committee on Research on Women’s Health on October 23...
The conference will provide a forum for young investigators, their mentors, and other research scientists to meet, present their research, and engage in networking activities.
The Global Health Program for Fellows and Scholars, funded by NIH’s Fogarty International Center, Office of Research on Women’s Health, and other Institutes and Centers, collaborates with U.S. university partners to provide mentored global health research training opportunities in low- and middle-income countries around the world.
Historically, surgeons have treated uterovaginal prolapse by removing the uterus (called a hysterectomy) and attaching the top of the vagina to deep pelvic ligaments. Mesh hysteropexy represents an alternative treatment, does not require a hysterectomy, and uses a mesh implant similar to the one shown in the photograph to support the uterus. 
This publication, often referred to as the “biennial report,” details the NIH-wide programs and accomplishments carried out in fulfillment of ORWH's core mission.
NIH recently released a Funding Opportunity Announcement (FOA) titled The Intersection of Sex and Gender Influences on Health and Disease for Research Project Grant (R01) applications on the influence and intersection of sex and gender in health and disease. This FOA encourages research across many scientific disciplines to examine how sex and gender factors intersect with health and disease.
A recent randomized clinical trial found that a procedure called mid-urethral sling surgery might help women who have both stress urinary incontinence and urgency urinary incontinence, together called mixed urinary incontinence.
A recent request for information (RFI) from ORWH invites comments and suggestions on the development of a prize recognizing institutions that have demonstrated commitment to addressing diversity and equity issues in biomedical and behavioral science departments.
The NIH Office of Research on Women’s Health (ORWH) has released an informational booklet on polycystic ovary/ovarian syndrome (PCOS), an endocrine disease affecting millions of women that is often missed during medical examination.

The Office of Research on Women’s Health (ORWH) recently added over 40 funding opportunity announcements (FOAs) to its website.

The website of NIH’s National Library of Medicine (NLM) recently created an online version of the awarding-winning exhibition “Changing the Face of Medicine: Celebrating America’s Women Physicians.”
A recent supplementary edition of Women’s Health Issues, sponsored by the Veterans Affairs (VA) Cooperative Studies Program, features research reports and commentaries on the growing number of women veterans and their unique health needs.
Dr. Clayton Answers Questions About This Common Eye Condition.

Over the past year, the Office of Research on Women’s Health (ORWH) has coordinated the development of a new 5-year plan that will set an updated agenda for expanding research on the health of women.

In a recent “Musings from the Mezzanine” blog post, Director of the National Library of Medicine (NLM) Patricia Flatley Brennan, RN, Ph.D., FAAN, FACMI, discusses a historic first: 10 women now lead NIH Institutes and Centers.

Working at NIH, I often see the amazing advancements and achievements made by the biomedical research enterprise. One recent important advance is not a scientific finding or new technology, but a strong stand on principle made by NIH Director Dr. Francis Collins.

Five goals for advancing science for the health of women.

ORWH Director Janine Clayton, M.D., and fellow ophthalmologist Claude Cowan, M.D., spoke on gout and inflammatory eye disease at the 14th Annual Kenneth Austin Rheumatology Symposium at Howard University Hospital on April 6.

On November 8 and 9, 2018, ORWH Director Janine Clayton, M.D., attended the second annual WLGH Conference, hosted by the London School of Hygiene & Tropical Medicine. The WLGH Conference convenes leaders from health, policy, and other sectors to discuss and promote gender equity in health leadership and thereby improve health for all.

On November 28, 2018, ORWH hosted the annual meeting of the BIRCWH program, which connects junior faculty (BIRCWH Scholars) to senior faculty mentors with shared research interest in women's health and sex-differences research.

At the 46th meeting of ACRWH on October 23, 2018, ORWH Director Janine Clayton, M.D., addressed increases in maternal mortality, decreasing life expectancies for women, and the effects of the opioid crisis on women’s health.